Mario Alberto Accardi's most recent trade in Centessa Pharmaceuticals plc - ADR was a trade of 273,000 Share Option (right to buy) done . Disclosure was reported to the exchange on Feb. 1, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Centessa Pharma PLC (ADR) | Mario Alberto Accardi | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2026 | 273,000 | 273,000 | - | - | Share Option (right to buy) | |
| Centessa Pharma PLC (ADR) | Mario Alberto Accardi | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2026 | 68,000 | 243,886 | - | 0 | Ordinary Shares | |
| Centessa Pharma PLC (ADR) | Mario Alberto Accardi | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.57 per share. | 01 Feb 2026 | 2,915 | 175,886 | - | 24.6 | 71,622 | Ordinary Shares |
| Centessa Pharma PLC (ADR) | Mario Alberto Accardi | President, Orexin Program | Sale of securities on an exchange or to another person at price $ 28.70 per share. | 09 Dec 2025 | 7,432 | 181,369 | - | 28.7 | 213,284 | Ordinary Shares |
| Centessa Pharma PLC (ADR) | Mario Alberto Accardi | President, Orexin Program | Sale of securities on an exchange or to another person at price $ 29.21 per share. | 09 Dec 2025 | 2,568 | 178,801 | - | 29.2 | 75,005 | Ordinary Shares |
| Centessa Pharma PLC (ADR) | Mario Alberto Accardi | President, Orexin Program | Sale of securities on an exchange or to another person at price $ 30.00 per share. | 08 Dec 2025 | 10,000 | 188,801 | - | 30 | 300,000 | Ordinary Shares |
| Centessa Pharma PLC (ADR) | Mario Alberto Accardi | President, Orexin Program | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.53 per share. | 08 Dec 2025 | 5,000 | 198,801 | - | 9.5 | 47,650 | Ordinary Shares |
| Centessa Pharma PLC (ADR) | Mario Alberto Accardi | President, Orexin Program | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 5,000 | 6,250 | - | - | Share Option (right to buy) | |
| Centessa Pharma PLC (ADR) | Mario Alberto Accardi | President, Orexin Program | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.90 per share. | 01 Nov 2025 | 593 | 193,801 | - | 24.9 | 14,766 | Ordinary Shares |
| Centessa Pharma PLC (ADR) | Mario Alberto Accardi | President, Orexin Program | Sale of securities on an exchange or to another person at price $ 25.00 per share. | 27 Oct 2025 | 8,000 | 194,394 | - | 25 | 200,000 | Ordinary Shares |
| Centessa Pharma PLC (ADR) | Mario Alberto Accardi | President, Orexin Program | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.01 per share. | 27 Oct 2025 | 5,000 | 202,394 | - | 8.0 | 40,050 | Ordinary Shares |
| Centessa Pharma PLC (ADR) | Mario Alberto Accardi | President, Orexin Program | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Oct 2025 | 5,000 | 30,000 | - | - | Share Option (right to buy) | |
| Centessa Pharma PLC (ADR) | Mario Alberto Accardi | President, Orexin Program | Sale of securities on an exchange or to another person at price $ 21.33 per share. | 16 Sep 2025 | 7,430 | 198,136 | - | 21.3 | 158,506 | Ordinary Shares |
| Centessa Pharma PLC (ADR) | Mario Alberto Accardi | President, Orexin Program | Sale of securities on an exchange or to another person at price $ 22.02 per share. | 16 Sep 2025 | 742 | 197,394 | - | 22.0 | 16,340 | Ordinary Shares |
| Centessa Pharma PLC (ADR) | Mario Alberto Accardi | President, Orexin Program | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 09 Sep 2025 | 7,000 | 205,566 | - | 20 | 140,000 | Ordinary Shares |
| Centessa Pharma PLC (ADR) | Mario Alberto Accardi | President, Orexin Program | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2025 | 5,000 | 35,000 | - | - | Share Option (right to buy) | |
| Centessa Pharma PLC (ADR) | Mario Alberto Accardi | President, Orexin Program | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.01 per share. | 09 Sep 2025 | 5,000 | 212,566 | - | 8.0 | 40,050 | Ordinary Shares |
| Centessa Pharma PLC (ADR) | Mario Alberto Accardi | President, Orexin Program | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.17 per share. | 01 Aug 2025 | 597 | 207,566 | - | 17.2 | 10,250 | Ordinary Shares |
| Centessa Pharma PLC (ADR) | Mario Alberto Accardi | President, Orexin Program | Sale of securities on an exchange or to another person at price $ 15.23 per share. | 29 Jul 2025 | 8,322 | 208,163 | - | 15.2 | 126,751 | Ordinary Shares |
| Centessa Pharma PLC (ADR) | Mario Alberto Accardi | President, Orexin Program | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jun 2025 | 15,000 | 15,300 | - | - | Share Option (right to buy) | |
| Centessa Pharma PLC (ADR) | Mario Alberto Accardi | President, Orexin Program | Sale of securities on an exchange or to another person at price $ 14.00 per share. | 24 Jun 2025 | 15,000 | 216,485 | - | 14 | 210,000 | Ordinary Shares |
| Centessa Pharma PLC (ADR) | Mario Alberto Accardi | President, Orexin Program | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.85 per share. | 24 Jun 2025 | 15,000 | 231,485 | - | 3.9 | 57,750 | Ordinary Shares |